The global market for Antipyretic Medicine for Elderly was valued at US$ 9589 million in the year 2024 and is projected to reach a revised size of US$ 10750 million by 2031, growing at a CAGR of 1.9% during the forecast period.

Antipyretic Medicine for Elderly Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Antipyretic Medicine for Elderly competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Antipyretics for the elderly are antipyretics designed specifically for the elderly, and are mainly used to treat fever symptoms caused by infection (such as influenza, pneumonia), inflammation or other diseases. Its core goal is to lower body temperature by regulating the body temperature center or promoting heat dissipation, while strictly taking into account the physiological characteristics of the elderly and drug safety to avoid adverse drug reactions.

North American market for Antipyretic Medicine for Elderly is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antipyretic Medicine for Elderly is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Antipyretic Medicine for Elderly include Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antipyretic Medicine for Elderly, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic Medicine for Elderly.

The Antipyretic Medicine for Elderly market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antipyretic Medicine for Elderly market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antipyretic Medicine for Elderly manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antipyretic Medicine for Elderly Market Report

Report Metric	Details
Report Name	Antipyretic Medicine for Elderly Market
Accounted market size in year	US$ 9589 million
Forecasted market size in 2031	US$ 10750 million
CAGR	1.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Acetaminophen Ibuprofen Other
Segment by Application	Online Sales Offline Sales
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, Anqiu Lu'an, Zhejiang Kangle, Hebei Jiheng, Novacyl, Anhui Fubore, Anhui BBCA Likang, Changshu Huagang
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antipyretic Medicine for Elderly manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antipyretic Medicine for Elderly in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Antipyretic Medicine for Elderly Market growing?

Ans: The Antipyretic Medicine for Elderly Market witnessing a CAGR of 1.9% during the forecast period 2025-2031.

What is the Antipyretic Medicine for Elderly Market size in 2031?

Ans: The Antipyretic Medicine for Elderly Market size in 2031 will be US$ 10750 million.

Who are the main players in the Antipyretic Medicine for Elderly Market report?

Ans: The main players in the Antipyretic Medicine for Elderly Market are Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, Anqiu Lu'an, Zhejiang Kangle, Hebei Jiheng, Novacyl, Anhui Fubore, Anhui BBCA Likang, Changshu Huagang

What are the Application segmentation covered in the Antipyretic Medicine for Elderly Market report?

Ans: The Applications covered in the Antipyretic Medicine for Elderly Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Antipyretic Medicine for Elderly Market report?

Ans: The Types covered in the Antipyretic Medicine for Elderly Market report are Acetaminophen, Ibuprofen, Other

1 Antipyretic Medicine for Elderly Market Overview

1.1 Product Definition

1.2 Antipyretic Medicine for Elderly by Type

1.2.1 Global Antipyretic Medicine for Elderly Market Value Comparison by Type (2024 VS 2031)

1.2.2 Acetaminophen

1.2.3 Ibuprofen

1.2.4 Other

1.3 Antipyretic Medicine for Elderly by Application

1.3.1 Global Antipyretic Medicine for Elderly Market Value by Application (2024 VS 2031)

1.3.2 Online Sales

1.3.3 Offline Sales

1.4 Global Antipyretic Medicine for Elderly Market Size Estimates and Forecasts

1.4.1 Global Antipyretic Medicine for Elderly Revenue 2020-2031

1.4.2 Global Antipyretic Medicine for Elderly Sales 2020-2031

1.4.3 Global Antipyretic Medicine for Elderly Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Antipyretic Medicine for Elderly Market Competition by Manufacturers

2.1 Global Antipyretic Medicine for Elderly Sales Market Share by Manufacturers (2020-2025)

2.2 Global Antipyretic Medicine for Elderly Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Antipyretic Medicine for Elderly Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Antipyretic Medicine for Elderly, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antipyretic Medicine for Elderly, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antipyretic Medicine for Elderly, Product Type & Application

2.7 Global Key Manufacturers of Antipyretic Medicine for Elderly, Date of Enter into This Industry

2.8 Global Antipyretic Medicine for Elderly Market Competitive Situation and Trends

2.8.1 Global Antipyretic Medicine for Elderly Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Antipyretic Medicine for Elderly Players Market Share by Revenue

2.8.3 Global Antipyretic Medicine for Elderly Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Antipyretic Medicine for Elderly Market Scenario by Region

3.1 Global Antipyretic Medicine for Elderly Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Antipyretic Medicine for Elderly Sales by Region: 2020-2031

3.2.1 Global Antipyretic Medicine for Elderly Sales by Region: 2020-2025

3.2.2 Global Antipyretic Medicine for Elderly Sales by Region: 2026-2031

3.3 Global Antipyretic Medicine for Elderly Revenue by Region: 2020-2031

3.3.1 Global Antipyretic Medicine for Elderly Revenue by Region: 2020-2025

3.3.2 Global Antipyretic Medicine for Elderly Revenue by Region: 2026-2031

3.4 North America Antipyretic Medicine for Elderly Market Facts & Figures by Country

3.4.1 North America Antipyretic Medicine for Elderly Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Antipyretic Medicine for Elderly Sales by Country (2020-2031)

3.4.3 North America Antipyretic Medicine for Elderly Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Antipyretic Medicine for Elderly Market Facts & Figures by Country

3.5.1 Europe Antipyretic Medicine for Elderly Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Antipyretic Medicine for Elderly Sales by Country (2020-2031)

3.5.3 Europe Antipyretic Medicine for Elderly Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antipyretic Medicine for Elderly Market Facts & Figures by Region

3.6.1 Asia Pacific Antipyretic Medicine for Elderly Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Antipyretic Medicine for Elderly Sales by Region (2020-2031)

3.6.3 Asia Pacific Antipyretic Medicine for Elderly Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Antipyretic Medicine for Elderly Market Facts & Figures by Country

3.7.1 Latin America Antipyretic Medicine for Elderly Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Antipyretic Medicine for Elderly Sales by Country (2020-2031)

3.7.3 Latin America Antipyretic Medicine for Elderly Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Antipyretic Medicine for Elderly Market Facts & Figures by Country

3.8.1 Middle East and Africa Antipyretic Medicine for Elderly Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Antipyretic Medicine for Elderly Sales by Country (2020-2031)

3.8.3 Middle East and Africa Antipyretic Medicine for Elderly Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Antipyretic Medicine for Elderly Sales by Type (2020-2031)

4.1.1 Global Antipyretic Medicine for Elderly Sales by Type (2020-2025)

4.1.2 Global Antipyretic Medicine for Elderly Sales by Type (2026-2031)

4.1.3 Global Antipyretic Medicine for Elderly Sales Market Share by Type (2020-2031)

4.2 Global Antipyretic Medicine for Elderly Revenue by Type (2020-2031)

4.2.1 Global Antipyretic Medicine for Elderly Revenue by Type (2020-2025)

4.2.2 Global Antipyretic Medicine for Elderly Revenue by Type (2026-2031)

4.2.3 Global Antipyretic Medicine for Elderly Revenue Market Share by Type (2020-2031)

4.3 Global Antipyretic Medicine for Elderly Price by Type (2020-2031)

5 Segment by Application

5.1 Global Antipyretic Medicine for Elderly Sales by Application (2020-2031)

5.1.1 Global Antipyretic Medicine for Elderly Sales by Application (2020-2025)

5.1.2 Global Antipyretic Medicine for Elderly Sales by Application (2026-2031)

5.1.3 Global Antipyretic Medicine for Elderly Sales Market Share by Application (2020-2031)

5.2 Global Antipyretic Medicine for Elderly Revenue by Application (2020-2031)

5.2.1 Global Antipyretic Medicine for Elderly Revenue by Application (2020-2025)

5.2.2 Global Antipyretic Medicine for Elderly Revenue by Application (2026-2031)

5.2.3 Global Antipyretic Medicine for Elderly Revenue Market Share by Application (2020-2031)

5.3 Global Antipyretic Medicine for Elderly Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Xinhua Pharmaceutical

6.1.1 Xinhua Pharmaceutical Company Information

6.1.2 Xinhua Pharmaceutical Description and Business Overview

6.1.3 Xinhua Pharmaceutical Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Xinhua Pharmaceutical Antipyretic Medicine for Elderly Product Portfolio

6.1.5 Xinhua Pharmaceutical Recent Developments/Updates

6.2 IOLCP

6.2.1 IOLCP Company Information

6.2.2 IOLCP Description and Business Overview

6.2.3 IOLCP Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.2.4 IOLCP Antipyretic Medicine for Elderly Product Portfolio

6.2.5 IOLCP Recent Developments/Updates

6.3 Granules Biocause

6.3.1 Granules Biocause Company Information

6.3.2 Granules Biocause Description and Business Overview

6.3.3 Granules Biocause Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Granules Biocause Antipyretic Medicine for Elderly Product Portfolio

6.3.5 Granules Biocause Recent Developments/Updates

6.4 Strides Shasun

6.4.1 Strides Shasun Company Information

6.4.2 Strides Shasun Description and Business Overview

6.4.3 Strides Shasun Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Strides Shasun Antipyretic Medicine for Elderly Product Portfolio

6.4.5 Strides Shasun Recent Developments/Updates

6.5 Mallinckrodt

6.5.1 Mallinckrodt Company Information

6.5.2 Mallinckrodt Description and Business Overview

6.5.3 Mallinckrodt Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Mallinckrodt Antipyretic Medicine for Elderly Product Portfolio

6.5.5 Mallinckrodt Recent Developments/Updates

6.6 Farmson

6.6.1 Farmson Company Information

6.6.2 Farmson Description and Business Overview

6.6.3 Farmson Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Farmson Antipyretic Medicine for Elderly Product Portfolio

6.6.5 Farmson Recent Developments/Updates

6.7 Granules India

6.7.1 Granules India Company Information

6.7.2 Granules India Description and Business Overview

6.7.3 Granules India Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Granules India Antipyretic Medicine for Elderly Product Portfolio

6.7.5 Granules India Recent Developments/Updates

6.8 SKPL

6.8.1 SKPL Company Information

6.8.2 SKPL Description and Business Overview

6.8.3 SKPL Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.8.4 SKPL Antipyretic Medicine for Elderly Product Portfolio

6.8.5 SKPL Recent Developments/Updates

6.9 Atabay

6.9.1 Atabay Company Information

6.9.2 Atabay Description and Business Overview

6.9.3 Atabay Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Atabay Antipyretic Medicine for Elderly Product Portfolio

6.9.5 Atabay Recent Developments/Updates

6.10 Temad

6.10.1 Temad Company Information

6.10.2 Temad Description and Business Overview

6.10.3 Temad Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Temad Antipyretic Medicine for Elderly Product Portfolio

6.10.5 Temad Recent Developments/Updates

6.11 Anqiu Lu'an

6.11.1 Anqiu Lu'an Company Information

6.11.2 Anqiu Lu'an Description and Business Overview

6.11.3 Anqiu Lu'an Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Anqiu Lu'an Antipyretic Medicine for Elderly Product Portfolio

6.11.5 Anqiu Lu'an Recent Developments/Updates

6.12 Zhejiang Kangle

6.12.1 Zhejiang Kangle Company Information

6.12.2 Zhejiang Kangle Description and Business Overview

6.12.3 Zhejiang Kangle Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Zhejiang Kangle Antipyretic Medicine for Elderly Product Portfolio

6.12.5 Zhejiang Kangle Recent Developments/Updates

6.13 Hebei Jiheng

6.13.1 Hebei Jiheng Company Information

6.13.2 Hebei Jiheng Description and Business Overview

6.13.3 Hebei Jiheng Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Hebei Jiheng Antipyretic Medicine for Elderly Product Portfolio

6.13.5 Hebei Jiheng Recent Developments/Updates

6.14 Novacyl

6.14.1 Novacyl Company Information

6.14.2 Novacyl Description and Business Overview

6.14.3 Novacyl Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Novacyl Antipyretic Medicine for Elderly Product Portfolio

6.14.5 Novacyl Recent Developments/Updates

6.15 Anhui Fubore

6.15.1 Anhui Fubore Company Information

6.15.2 Anhui Fubore Description and Business Overview

6.15.3 Anhui Fubore Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Anhui Fubore Antipyretic Medicine for Elderly Product Portfolio

6.15.5 Anhui Fubore Recent Developments/Updates

6.16 Anhui BBCA Likang

6.16.1 Anhui BBCA Likang Company Information

6.16.2 Anhui BBCA Likang Description and Business Overview

6.16.3 Anhui BBCA Likang Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Anhui BBCA Likang Antipyretic Medicine for Elderly Product Portfolio

6.16.5 Anhui BBCA Likang Recent Developments/Updates

6.17 Changshu Huagang

6.17.1 Changshu Huagang Company Information

6.17.2 Changshu Huagang Description and Business Overview

6.17.3 Changshu Huagang Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Changshu Huagang Antipyretic Medicine for Elderly Product Portfolio

6.17.5 Changshu Huagang Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antipyretic Medicine for Elderly Industry Chain Analysis

7.2 Antipyretic Medicine for Elderly Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antipyretic Medicine for Elderly Production Mode & Process Analysis

7.4 Antipyretic Medicine for Elderly Sales and Marketing

7.4.1 Antipyretic Medicine for Elderly Sales Channels

7.4.2 Antipyretic Medicine for Elderly Distributors

7.5 Antipyretic Medicine for Elderly Customer Analysis

8 Antipyretic Medicine for Elderly Market Dynamics

8.1 Antipyretic Medicine for Elderly Industry Trends

8.2 Antipyretic Medicine for Elderly Market Drivers

8.3 Antipyretic Medicine for Elderly Market Challenges

8.4 Antipyretic Medicine for Elderly Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Xinhua Pharmaceutical

List of Tables

Table 1. Global Antipyretic Medicine for Elderly Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Antipyretic Medicine for Elderly Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Antipyretic Medicine for Elderly Market Competitive Situation by Manufacturers in 2024

Table 4. Global Antipyretic Medicine for Elderly Sales (K Dose) of Key Manufacturers (2020-2025)

Table 5. Global Antipyretic Medicine for Elderly Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Antipyretic Medicine for Elderly Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Antipyretic Medicine for Elderly Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Antipyretic Medicine for Elderly Average Price (US$/Dose) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Antipyretic Medicine for Elderly, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antipyretic Medicine for Elderly, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antipyretic Medicine for Elderly, Product Type & Application

Table 12. Global Key Manufacturers of Antipyretic Medicine for Elderly, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antipyretic Medicine for Elderly by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipyretic Medicine for Elderly as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antipyretic Medicine for Elderly Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Antipyretic Medicine for Elderly Sales by Region (2020-2025) & (K Dose)

Table 18. Global Antipyretic Medicine for Elderly Sales Market Share by Region (2020-2025)

Table 19. Global Antipyretic Medicine for Elderly Sales by Region (2026-2031) & (K Dose)

Table 20. Global Antipyretic Medicine for Elderly Sales Market Share by Region (2026-2031)

Table 21. Global Antipyretic Medicine for Elderly Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Antipyretic Medicine for Elderly Revenue Market Share by Region (2020-2025)

Table 23. Global Antipyretic Medicine for Elderly Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Antipyretic Medicine for Elderly Revenue Market Share by Region (2026-2031)

Table 25. North America Antipyretic Medicine for Elderly Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Antipyretic Medicine for Elderly Sales by Country (2020-2025) & (K Dose)

Table 27. North America Antipyretic Medicine for Elderly Sales by Country (2026-2031) & (K Dose)

Table 28. North America Antipyretic Medicine for Elderly Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Antipyretic Medicine for Elderly Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Antipyretic Medicine for Elderly Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Antipyretic Medicine for Elderly Sales by Country (2020-2025) & (K Dose)

Table 32. Europe Antipyretic Medicine for Elderly Sales by Country (2026-2031) & (K Dose)

Table 33. Europe Antipyretic Medicine for Elderly Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Antipyretic Medicine for Elderly Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Antipyretic Medicine for Elderly Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Antipyretic Medicine for Elderly Sales by Region (2020-2025) & (K Dose)

Table 37. Asia Pacific Antipyretic Medicine for Elderly Sales by Region (2026-2031) & (K Dose)

Table 38. Asia Pacific Antipyretic Medicine for Elderly Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Antipyretic Medicine for Elderly Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antipyretic Medicine for Elderly Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Antipyretic Medicine for Elderly Sales by Country (2020-2025) & (K Dose)

Table 42. Latin America Antipyretic Medicine for Elderly Sales by Country (2026-2031) & (K Dose)

Table 43. Latin America Antipyretic Medicine for Elderly Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Antipyretic Medicine for Elderly Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Antipyretic Medicine for Elderly Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Antipyretic Medicine for Elderly Sales by Country (2020-2025) & (K Dose)

Table 47. Middle East and Africa Antipyretic Medicine for Elderly Sales by Country (2026-2031) & (K Dose)

Table 48. Middle East and Africa Antipyretic Medicine for Elderly Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Antipyretic Medicine for Elderly Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Antipyretic Medicine for Elderly Sales (K Dose) by Type (2020-2025)

Table 51. Global Antipyretic Medicine for Elderly Sales (K Dose) by Type (2026-2031)

Table 52. Global Antipyretic Medicine for Elderly Sales Market Share by Type (2020-2025)

Table 53. Global Antipyretic Medicine for Elderly Sales Market Share by Type (2026-2031)

Table 54. Global Antipyretic Medicine for Elderly Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Antipyretic Medicine for Elderly Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Antipyretic Medicine for Elderly Revenue Market Share by Type (2020-2025)

Table 57. Global Antipyretic Medicine for Elderly Revenue Market Share by Type (2026-2031)

Table 58. Global Antipyretic Medicine for Elderly Price (US$/Dose) by Type (2020-2025)

Table 59. Global Antipyretic Medicine for Elderly Price (US$/Dose) by Type (2026-2031)

Table 60. Global Antipyretic Medicine for Elderly Sales (K Dose) by Application (2020-2025)

Table 61. Global Antipyretic Medicine for Elderly Sales (K Dose) by Application (2026-2031)

Table 62. Global Antipyretic Medicine for Elderly Sales Market Share by Application (2020-2025)

Table 63. Global Antipyretic Medicine for Elderly Sales Market Share by Application (2026-2031)

Table 64. Global Antipyretic Medicine for Elderly Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Antipyretic Medicine for Elderly Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Antipyretic Medicine for Elderly Revenue Market Share by Application (2020-2025)

Table 67. Global Antipyretic Medicine for Elderly Revenue Market Share by Application (2026-2031)

Table 68. Global Antipyretic Medicine for Elderly Price (US$/Dose) by Application (2020-2025)

Table 69. Global Antipyretic Medicine for Elderly Price (US$/Dose) by Application (2026-2031)

Table 70. Xinhua Pharmaceutical Company Information

Table 71. Xinhua Pharmaceutical Description and Business Overview

Table 72. Xinhua Pharmaceutical Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 73. Xinhua Pharmaceutical Antipyretic Medicine for Elderly Product

Table 74. Xinhua Pharmaceutical Recent Developments/Updates

Table 75. IOLCP Company Information

Table 76. IOLCP Description and Business Overview

Table 77. IOLCP Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 78. IOLCP Antipyretic Medicine for Elderly Product

Table 79. IOLCP Recent Developments/Updates

Table 80. Granules Biocause Company Information

Table 81. Granules Biocause Description and Business Overview

Table 82. Granules Biocause Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 83. Granules Biocause Antipyretic Medicine for Elderly Product

Table 84. Granules Biocause Recent Developments/Updates

Table 85. Strides Shasun Company Information

Table 86. Strides Shasun Description and Business Overview

Table 87. Strides Shasun Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 88. Strides Shasun Antipyretic Medicine for Elderly Product

Table 89. Strides Shasun Recent Developments/Updates

Table 90. Mallinckrodt Company Information

Table 91. Mallinckrodt Description and Business Overview

Table 92. Mallinckrodt Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 93. Mallinckrodt Antipyretic Medicine for Elderly Product

Table 94. Mallinckrodt Recent Developments/Updates

Table 95. Farmson Company Information

Table 96. Farmson Description and Business Overview

Table 97. Farmson Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 98. Farmson Antipyretic Medicine for Elderly Product

Table 99. Farmson Recent Developments/Updates

Table 100. Granules India Company Information

Table 101. Granules India Description and Business Overview

Table 102. Granules India Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 103. Granules India Antipyretic Medicine for Elderly Product

Table 104. Granules India Recent Developments/Updates

Table 105. SKPL Company Information

Table 106. SKPL Description and Business Overview

Table 107. SKPL Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 108. SKPL Antipyretic Medicine for Elderly Product

Table 109. SKPL Recent Developments/Updates

Table 110. Atabay Company Information

Table 111. Atabay Description and Business Overview

Table 112. Atabay Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 113. Atabay Antipyretic Medicine for Elderly Product

Table 114. Atabay Recent Developments/Updates

Table 115. Temad Company Information

Table 116. Temad Description and Business Overview

Table 117. Temad Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 118. Temad Antipyretic Medicine for Elderly Product

Table 119. Temad Recent Developments/Updates

Table 120. Anqiu Lu'an Company Information

Table 121. Anqiu Lu'an Description and Business Overview

Table 122. Anqiu Lu'an Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 123. Anqiu Lu'an Antipyretic Medicine for Elderly Product

Table 124. Anqiu Lu'an Recent Developments/Updates

Table 125. Zhejiang Kangle Company Information

Table 126. Zhejiang Kangle Description and Business Overview

Table 127. Zhejiang Kangle Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 128. Zhejiang Kangle Antipyretic Medicine for Elderly Product

Table 129. Zhejiang Kangle Recent Developments/Updates

Table 130. Hebei Jiheng Company Information

Table 131. Hebei Jiheng Description and Business Overview

Table 132. Hebei Jiheng Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 133. Hebei Jiheng Antipyretic Medicine for Elderly Product

Table 134. Hebei Jiheng Recent Developments/Updates

Table 135. Novacyl Company Information

Table 136. Novacyl Description and Business Overview

Table 137. Novacyl Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 138. Novacyl Antipyretic Medicine for Elderly Product

Table 139. Novacyl Recent Developments/Updates

Table 140. Anhui Fubore Company Information

Table 141. Anhui Fubore Description and Business Overview

Table 142. Anhui Fubore Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 143. Anhui Fubore Antipyretic Medicine for Elderly Product

Table 144. Anhui Fubore Recent Developments/Updates

Table 145. Anhui BBCA Likang Company Information

Table 146. Anhui BBCA Likang Description and Business Overview

Table 147. Anhui BBCA Likang Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 148. Anhui BBCA Likang Antipyretic Medicine for Elderly Product

Table 149. Anhui BBCA Likang Recent Developments/Updates

Table 150. Changshu Huagang Company Information

Table 151. Changshu Huagang Description and Business Overview

Table 152. Changshu Huagang Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 153. Changshu Huagang Antipyretic Medicine for Elderly Product

Table 154. Changshu Huagang Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Antipyretic Medicine for Elderly Distributors List

Table 158. Antipyretic Medicine for Elderly Customers List

Table 159. Antipyretic Medicine for Elderly Market Trends

Table 160. Antipyretic Medicine for Elderly Market Drivers

Table 161. Antipyretic Medicine for Elderly Market Challenges

Table 162. Antipyretic Medicine for Elderly Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Antipyretic Medicine for Elderly

Figure 2. Global Antipyretic Medicine for Elderly Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antipyretic Medicine for Elderly Market Share by Type: 2024 & 2031

Figure 4. Acetaminophen Product Picture

Figure 5. Ibuprofen Product Picture

Figure 6. Other Product Picture

Figure 7. Global Antipyretic Medicine for Elderly Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Antipyretic Medicine for Elderly Market Share by Application: 2024 & 2031

Figure 9. Online Sales

Figure 10. Offline Sales

Figure 11. Global Antipyretic Medicine for Elderly Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Antipyretic Medicine for Elderly Market Size (2020-2031) & (US$ Million)

Figure 13. Global Antipyretic Medicine for Elderly Sales (2020-2031) & (K Dose)

Figure 14. Global Antipyretic Medicine for Elderly Average Price (US$/Dose) & (2020-2031)

Figure 15. Antipyretic Medicine for Elderly Report Years Considered

Figure 16. Antipyretic Medicine for Elderly Sales Share by Manufacturers in 2024

Figure 17. Global Antipyretic Medicine for Elderly Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Antipyretic Medicine for Elderly Players: Market Share by Revenue in Antipyretic Medicine for Elderly in 2024

Figure 19. Antipyretic Medicine for Elderly Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Antipyretic Medicine for Elderly Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Antipyretic Medicine for Elderly Sales Market Share by Country (2020-2031)

Figure 22. North America Antipyretic Medicine for Elderly Revenue Market Share by Country (2020-2031)

Figure 23. United States Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Antipyretic Medicine for Elderly Sales Market Share by Country (2020-2031)

Figure 26. Europe Antipyretic Medicine for Elderly Revenue Market Share by Country (2020-2031)

Figure 27. Germany Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Antipyretic Medicine for Elderly Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Antipyretic Medicine for Elderly Revenue Market Share by Region (2020-2031)

Figure 34. China Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Antipyretic Medicine for Elderly Sales Market Share by Country (2020-2031)

Figure 42. Latin America Antipyretic Medicine for Elderly Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Antipyretic Medicine for Elderly Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Antipyretic Medicine for Elderly Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Antipyretic Medicine for Elderly Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Antipyretic Medicine for Elderly by Type (2020-2031)

Figure 53. Global Revenue Market Share of Antipyretic Medicine for Elderly by Type (2020-2031)

Figure 54. Global Antipyretic Medicine for Elderly Price (US$/Dose) by Type (2020-2031)

Figure 55. Global Sales Market Share of Antipyretic Medicine for Elderly by Application (2020-2031)

Figure 56. Global Revenue Market Share of Antipyretic Medicine for Elderly by Application (2020-2031)

Figure 57. Global Antipyretic Medicine for Elderly Price (US$/Dose) by Application (2020-2031)

Figure 58. Antipyretic Medicine for Elderly Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Antipyretic Medicine for Elderly Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-18Z19308

Global Antipyretic Medicine for Elderly Market Research Report 2025

FEATURED COMPANIES

Antipyretic Medicine for Elderly Market Size

Antipyretic Medicine for Elderly Market

Report Scope

Scope of Antipyretic Medicine for Elderly Market Report

Core Chapters

FAQ for this report

How fast is Antipyretic Medicine for Elderly Market growing?

What is the Antipyretic Medicine for Elderly Market size in 2031?

Who are the main players in the Antipyretic Medicine for Elderly Market report?

What are the Application segmentation covered in the Antipyretic Medicine for Elderly Market report?

What are the Type segmentation covered in the Antipyretic Medicine for Elderly Market report?

FEATURED COMPANIES

RELATED REPORTS